XML 8 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 201,693 $ 295,305
Receivables, net of allowance for doubtful accounts 115,056 84,325
Inventories:    
Finished goods 26,180 24,022
Work in process 30,291 36,705
Raw materials 96,156 82,681
Total inventories 152,627 143,408
Prepaid expenses and other current assets 25,210 17,078
Total current assets 494,586 540,116
Property, plant and equipment, at cost 246,217 233,203
Less accumulated depreciation (167,855) (158,943)
Net property, plant and equipment 78,362 74,260
Intangible assets, at cost less accumulated amortization 122,060 45,066
Other assets 13,955 12,676
Deferred income taxes 32,653 32,525
Goodwill 236,654 111,770
Total assets 978,270 816,413
Current liabilities:    
Payables 69,786 55,659
Accrued compensation and employee benefits 33,524 34,912
Warranty and after-sale costs, current 8,926 7,283
Other current liabilities 41,186 20,351
Total current liabilities 153,422 118,205
Long-term deferred revenue 69,180 64,153
Deferred income taxes 24,065 3,652
Accrued non-pension postretirement benefits 3,395 3,033
Other accrued employee benefits 6,447 6,927
Warranty and after-sale costs, long-term 12,833 9,410
Other long-term liabilities 6,418 4,801
Commitments and contingencies (Note 5)
Shareholders’ equity:    
Common stock, $1 par, authorized 80,000,000, issued 37,221,098 shares in 2025 and 2024 37,221 37,221
Capital in excess of par value 72,541 65,819
Reinvested earnings 624,054 547,796
Accumulated other comprehensive income (loss) 5,115 (7,906)
Less: Treasury stock, at cost, 7,751,313 shares in 2025 and 7,810,158 in 2024 (36,421) (36,698)
Total shareholders’ equity 702,510 606,232
Total liabilities and shareholders’ equity $ 978,270 $ 816,413